Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Apr 8.

Published in final edited form as: J Pediatr Surg. 2009 Jun;44(6):1173–1180. doi: 10.1016/j.jpedsurg.2009.02.043

Table 3.

Postnatal treatment variables in neonates with and without CDH recurrence

	Recurrence (n=24)	No Recurrence (n=214)	P

ECMO	6 (25%)	40 (19%)	0.42
Thoracoscopic Repair	2 (8.3%)	5 (2.3%)	0.15
Diaphragm Prosthesis	16 (67%)	94 (44%)	0.05
Age at 1^st Repair, days ^†	5.5 (3.0 – 8.8)	4.0 (2.0 – 6.0)	0.02
Abdominal Wall Prosthesis	10 (42%)	39 (18%)	0.01
Postoperative LOS, days ^†	44 (22 – 153)	20 (10 – 36)	<0.01

Morbidity^*	15 (62%)	77 (36%)	0.01
Survival	21 (88%)	187 (87%)	0.99

^†

Data reported as median and interquartile range (i.e., 25^th – 75^th percentile).

^*

As defined in Methods – organ system dysfunction persisting beyond 6 months of age.